Announced
Completed
BIND THERAPEUTICS INC / PFIZER INC. / Acquisition / Private / £29m
Synopsis
Sale of BIND Therapeutics, a clinical-stage developer of Accurins, highly selective targeted and programmable biopharmaceutical therapeutics, to Pfizer, via a stalking horse bankruptcy auction.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2025 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.